CABAZITAXEL
Natco Pharma's partner Breckenridge Pharmaceutical gets FDA nod for prostate cancer treatment drug
Natco Pharma files new drug applications with USFDAThe company has filed Abbreviated New Drug Applications for Fingolimod, 0.5 mg capsules and Cabazitaxel, 60mg/ 1.5ml injection with the USF...
- Load More